Coherus Oncology, Inc 10-K for FY2025
Coherus Oncology, Inc. (CHRS)
10-K
2026-03-09
For: 2025-12-31
View Original
Added on
April 09, 2026
About this 10-K
Coherus Oncology, Inc filed this 10-K on March 9, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $42.17M
- up 59.8% from $26.39M a year earlier
- Net income
- $168.02M
- up 489.4% from net income of $28.51M a year earlier
- Diluted EPS
- $1.43
- up 472.0% from $0.25 a year earlier